Amicus Therapeutics
Climate Impact & Sustainability Data (2022, 2023)
Reporting Period: 2022
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Environmental Stewardship
- Human Capital
- Governance
Environmental Achievements
- Identified areas of risk and opportunities in our partner's sustainability programs.
- Enforced contractual obligations with suppliers to uphold good sustainability practices through their own ESG programs.
- Engaged employees around good sustainability practices through the GREEN employee resource group (ERG) to further educate on how Amicus and individuals can reduce our carbon footprint.
- Greater efforts towards reducing our carbon footprint through a reduction in our facilities, increased hybrid working, and occupying office space that is commutable by walking, mass transit, or shared rides.
Social Achievements
- Increased access to Galafold to more than 2,000 people living with Fabry disease around the world
- Provided AT-GAA to nearly 200 people living with Pompe disease through our clinical studies and Expanded Access programs
- Supported a mission-focused culture where employees can contribute to winning teams, feel included, supported, and heard
- Launched Employee Resource Groups (ERGs) to foster a diverse and inclusive workplace.
- Certified over 50 trained Mental Health First Aiders globally.
Governance Achievements
- Reinforced our culture of strong business ethics and sound corporate governance philosophies
- Continued to integrate sustainability best practices in our operations and with our partners while delivering strong business growth
- Adopted a Code of Conduct, which applies to all of our officers, directors, and employees
- Updated charters for our Audit and Compliance Committee, our Compensation and Leadership Development Committee, our Nominating and Corporate Governance Committee, and our Science and Technology Committee.
Climate Goals & Targets
Long-term Goals:
- Carbon neutrality
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Minimizing environmental footprint as a biotechnology company.
- Gaining a better understanding of both Amicus' and our partners' GHG emissions and pursuing reduction targets to achieve our aspirational goal of carbon neutrality.
Mitigation Strategies
- Building out a robust sustainability program.
- Working towards implementing sustainability objectives into our operations and with our manufacturing and supply partners to achieve a reduction in greenhouse gas (GHG) emissions.
- Completed an initial review of ESG programs with all direct suppliers.
- Incorporated environmental and sustainability clauses into supplier contracts.
Supply Chain Management
Supplier Audits: Initial review of ESG programs with all direct suppliers completed in 2022.
Responsible Procurement
- Incorporating environmental and sustainability clauses into supplier contracts.
- ESG questionnaire for new suppliers.
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: SASB
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Goal 3 (Good Health and Well-being)
- Goal 8 (Decent Work and Economic Growth)
- Goal 12 (Responsible Consumption and Production)
- Goal 17 (Partnerships for the Goals)
Amicus' initiatives contribute to these goals through its focus on patient care, employee well-being, sustainable business practices, and collaborations with partners.
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:0% Scope 1 and 2 GHG emissions
ESG Focus Areas
- Environmental Stewardship
- Patients
- Employees
- Governance
Environmental Achievements
- Continued to capture risk and opportunities in our partners’ sustainability programs
- Implemented contractual obligations with suppliers to maintain good sustainability practices
- Engaged employees around good sustainability practices
- Greater efforts towards reducing our carbon footprint
Social Achievements
- Increasing access to Galafold with over 2,400 people living with Fabry disease around the world
- Receiving regulatory approvals of our second commercial therapy, Pombiliti™ + Opfolda™, in the United States, European Union, and the United Kingdom
- Supporting a mission-focused culture where employees can contribute to winning teams, feel included, supported, and heard.
- Supporting our communities through global charitable giving
Governance Achievements
- Furthering our culture of strong business ethics and sound corporate governance philosophies
- Maintaining and fostering our culture of strong business ethics and integrity, and ensuring open lines of communication to encourage employee compliance reporting
- Continuing partnering with all employees and stakeholders to ensure transparency and proper training on policies, procedures, and best practices
- Robust risk oversight by senior leadership and the Board of Directors
Climate Goals & Targets
Long-term Goals:
- carbon neutrality
Environmental Challenges
- Reducing our carbon footprint as a biotechnology company
- Quantifying CO2 emissions produced during the supply chain
- Understanding both Amicus' and our partners' GHG emissions and developing reduction targets to achieve carbon neutrality
Mitigation Strategies
- Working towards implementing robust sustainability objectives into our operations and with our manufacturing and supply partners to achieve a reduction in greenhouse gas (GHG) emissions
- Engaging with CDP to gain a better understanding of GHG emissions and create a basis for direct action to improve sustainability
- Developing sustainability objectives with our manufacturing and supply partners to reduce GHG emissions
- Implementing contractual obligations with suppliers to maintain good sustainability practices
Supply Chain Management
Responsible Procurement
- ESG clauses within supplier contracts
- Annual review of ESG performance across direct suppliers
- Deep-dive reviews of sustainability programs with key partners
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: SASB
UN Sustainable Development Goals
- Goal 7 (Affordable and Clean Energy)
- Goal 8 (Decent Work and Economic Growth)
- Goal 10 (Reduced Inequalities)
- Goal 3 (Good Health and Well-being)
- Goal 17 (Partnerships for the Goals)
Amicus aligns its ESG initiatives with several UN Sustainable Development Goals.
Awards & Recognition
- 2023 Champion of Board Diversity (Forum of Executive Women)